PATENT CLAIM ANALYSIS

Application Number: 16218010
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["424", "187100"]

Abstract:
The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.

Claim (Index 19):
The method of  claim 15 , further comprising infusing or having infused the transduced PBMC into a subject.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 98.0
- Lexical Diversity: 1.12903
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15668223', '16011550', '15652080', '15904131', '14254771']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7959472215272358
- 35 USC 102 Novelty (BERT): 0.6693036397075116
- Combined Prediction Score: 0.7832828633452634
- Mean Citation Score: 538.5949800000002
- Max Citation Score: 771.36084
- Similarity Product: 628.5024401819803

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test